Adjuvant treatment with the combination of abemaciclib and endocrine therapy (ET) maintained a benefit in invasive disease-free survival and distant relapse–free survival compared with ET alone in patients with hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer.
This study used national surveillance data from the Society for Assisted Reproductive Technology to describe trends and outcomes in assisted reproductive techno
The National Institutes of Health has selected researchers from Morehouse School of Medicine and Emory University’s Rollins School of Public Health and School of Medicine to partner on the creation of a Maternal Health Research Center of Excellence.
Emory, Morehouse to Launch Maternal Health Research Center miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.